Call Us Today
+44 (0) 20 7088 8240
+44 (0) 20 7088 8240
The global medicinal cannabis market is undergoing a structural shift. Regulatory reform across Europe, combined with growing clinical evidence and patient demand, is creating a multi-billion-pound opportunity that is still in its earliest stages.
Germany legalised medicinal cannabis in 2017 with statutory health insurance reimbursement. Patient numbers grow year-on-year. Partial recreational legalisation in 2024 further normalised cannabis and expanded the addressable market.
Across the EU, the Czech Republic, Poland, Italy, France, Portugal, Malta, Luxembourg and Denmark all have active medicinal cannabis frameworks. Each new market creates incremental demand for pharmaceutical-grade, GMP-certified product.
European domestic cultivation capacity remains structurally insufficient. The continent relies heavily on imports. This creates a clear opening for low-cost, high-quality African producers with GACP-certified supply chains and a clear pathway to GMP.
The global cannabis concentrates and extracts market is the fastest-growing segment. Rosin, as a solventless extract, commands a significant premium due to its pharmaceutical purity profile and growing consumer preference for clean-label products.
.
While Europe is our primary target, one of the fastest-growing medicinal cannabis markets in the world is right on our doorstep. South Africa is home to a domestic medical cannabis market serving a population of over 60 million people and is rapidly emerging as one of the largest cannabis markets on the continent. Lesotho, entirely surrounded by South Africa, is uniquely positioned to supply this market with minimal logistics and no cross-continental shipping. As South Africa’s regulatory framework matures and patient access expands, this represents a significant near-term revenue opportunity that complements our European export strategy.
Europe is the prize. South Africa is the opportunity next door. From Lesotho, we can serve both.
Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.
Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.
Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.
Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.
The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.
Cultivating Growth. Delivering Global Medical Cannabis Excellence.
New Frontier Holdings Ltd
First Floor 690 Great West Road, Osterley Village, Isleworth, England TW7 4PU
Company No. 12111072
England & Wales
Frontier Botanics Lesotho (Proprietary) Limited, Morena Khoase Kolobe, Mohalalitoe Road Maseru, Kingdom of Lesotho
© 2026 New Frontier Holdings Ltd.
